US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Modalis Therapeutics Corp
TSE:4883
Modalis Therapeutics Corp
Common Shares Outstanding
Modalis Therapeutics Corp
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Modalis Therapeutics Corp
TSE:4883
|
Common Shares Outstanding
ÂĄ33.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Common Shares Outstanding
ÂĄ49.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
PeptiDream Inc
TSE:4587
|
Common Shares Outstanding
ÂĄ129.6m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
Takara Bio Inc
TSE:4974
|
Common Shares Outstanding
ÂĄ120.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Common Shares Outstanding
ÂĄ28.1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
2%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Common Shares Outstanding
ÂĄ40.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Modalis Therapeutics Corp's Common Shares Outstanding?
Common Shares Outstanding
33.4m
JPY
Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Common Shares Outstanding amounts to 33.4m JPY.
What is Modalis Therapeutics Corp's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
11%
Over the last year, the Common Shares Outstanding growth was 14%. The average annual Common Shares Outstanding growth rates for Modalis Therapeutics Corp have been 5% over the past three years , 11% over the past five years .